Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.
Sara HeebøllRime Bahij El-HouriYlva Erika Kristina HellbergDavid HaldrupSteen Bønløkke PedersenNiels JessenLars Porskjaer ChristensenHenning GrønbaekPublished in: Journal of gastroenterology and hepatology (2016)
These experimental findings suggest that a weak hepatic benefit of RSV treatment is seen in prevention of steatosis only.